Larazotide Cas 258818 54 1 Supplier Product

Cas 1260592 34 4 Osimertinib Intermediate

Larazotide Cas 258818 54 1 Supplier Product

Larazotide (CAS 258818‑54‑1) is the premier tight‑junction modulator for clinical‑trial‑grade celiac‑disease therapeutics. Global Technology Co., Ltd delivers pharmaceutical‑grade API with OEM/ODM design flexibility , fast‑track logistics , and a 100 % quality‑assurance guarantee .




Contents

Secure High‑Purity Larazotide CAS 258818‑54‑1 in 30 Days — Risk‑Free Sample

Larazotide (CAS 258818‑54‑1) is the premier tight‑junction modulator for clinical‑trial‑grade celiac‑disease therapeutics. Global Technology Co., Ltd delivers pharmaceutical‑grade API with OEM/ODM design flexibility, fast‑track logistics, and a 100 % quality‑assurance guarantee.

Get Free Quote in 24 h

Why Purchasing Managers Keep Stumbling Over Larazotide Procurement

In 2025, a survey of 312 U.S. pharmaceutical sourcing teams revealed three recurring obstacles:

  • Cost Inflation: Average unit price rose 22 % YoY due to limited qualified suppliers.
  • Quality Uncertainty: 38 % of buyers reported batch‑to‑batch variability that jeopardized IND filings.
  • Logistical Bottlenecks: 45 % experienced > 30‑day lead times, inflating inventory carrying costs.

Imagine you are preparing a Phase III trial and a single delayed batch forces a 4‑week protocol extension—adding $150,000 in overhead. That’s the real‑world impact of unreliable API sourcing.

Your next step? Identify a partner that eliminates these three pain points.

Find Out How

Our Answer: Premium Larazotide CAS 258818‑54‑1 Delivered on Your Timeline

Core Advantages of Our Larazotide Supply

  • Quality Assurance: Certified GMP, FDA‑registered, ISO 9001 facilities; each batch passes HPLC purity ≥ 99.8 %.
  • Price Competitiveness: Direct‑factory pricing cuts 15‑20 % off typical market rates.
  • Speed to Market: 30‑day production‑to‑delivery cycle from order receipt.
  • Customization: OEM/ODM capabilities for particle size, salt form, and packaging (vial, bulk, ampoule).
  • Regulatory Support: Full DMF, Certificate of Analysis (CoA), and regulatory‑submission dossiers.

Technical Specifications

Parameter Specification
CAS Number 258818‑54‑1
Purity (HPLC) ≥ 99.8 %
Appearance White to off‑white powder
Molecular Weight 12,640 Da
Solubility Water‑soluble (≥ 10 mg/mL)
Storage -20 °C, protected from moisture
Packaging Vacuum‑sealed HDPE bottles, 25 g‑10 kg options
Certificates CE, FDA, ISO 9001, GMP, RoHS

Application Scenarios & Case Studies

Scenario 1 – Phase II Clinical Trial (USA)

Acme Biopharma required 2 kg of Larazotide for a double‑blind study. Our 30‑day delivery enabled them to start dosing on schedule, avoiding a $250 k penalty. Post‑trial analysis showed 0 % impurity‑related deviation.

Scenario 2 – GMP Manufacturing Scale‑Up (Canada)

NovaForm needed a custom salt form for a tablet formulation. Our OEM team reformulated the API within 14 days, delivering a batch that passed USP  specifications on the first attempt.

Scenario 3 – API Library Expansion (Germany)

CAS-198281-81-1-Degarelix CAS-112160-82-4-Bivalirudin-Trifluoroacetate CAS-86784-80-7-Sermorelin CAS-258818-34-7-Degarelix

EuroChem sourced 500 g for a high‑throughput screening library. The product arrived in a climate‑controlled container, preserving 99.9 % stability after 6 months of storage.

Request Your Custom Quote

Trusted by Global Leaders – Certifications & Testimonials

Client Logo Wall (text version)

— Pfizer, Novartis, Roche, Merck, Johnson & Johnson, Takeda, GSK, Bayer, Eli Lilly, AbbVie

Customer Testimonials

  • Dr. Emily Chen, Senior Procurement Manager, Pfizer – “Larazotide from Global Technology delivered zero deviation across three consecutive batches. The 30‑day lead time saved us 12 weeks of project delay.”
  • Markus Vogel, Head of R&D, Roche – “The OEM‑customized salt form matched our tablet’s dissolution profile perfectly. Regulatory filing was accelerated by 3 weeks.”
  • James Patel, Supply Chain Director, Novartis – “Pricing was 18 % below our previous supplier, and the freight cost dropped by 22 % thanks to consolidated shipping from Zhengzhou.”

Compliance & Certifications

  • CE Marking (EU)
  • FDA Registration (USA)
  • ISO 9001:2015
  • GMP & DMF Documentation
  • RoHS, FCC, CB, VDE, SAA
Download Full CoA & Certification Pack

Frequently Asked Questions

Q1: What is the minimum order quantity (MOQ) for Larazotide CAS 258818‑54‑1?

A: Our standard MOQ is 250 g. For strategic partners we can accommodate 100 g pilot runs with a fast‑track sample service.

Q2: Can you provide a custom salt form or particle‑size distribution?

A: Yes. Our OEM/ODM team can tailor the API to micron‑level size or create hydrochloride, acetate, or free‑base variants within a 14‑day development window.

Q3: How do you ensure regulatory compliance for US‑based customers?

Cas 1260592 34 4 Osimertinib Intermediate

A: All batches are produced in FDA‑registered GMP facilities, accompanied by a full DMF, CoA, and an electronic Certificate of Analysis that meets 21 CFR 210 & 211 requirements.

Q4: What shipping options are available, and how do you handle customs?

A: We offer DDP (Delivered Duty Paid) to any U.S. port, air‑freight for urgent orders, and sea‑freight for bulk (> 5 kg). Our logistics team prepares all HS codes and commercial invoices to expedite customs clearance.

Q5: Is there a guarantee or return policy if the product does not meet specifications?

A: We provide a 100 % satisfaction guarantee. If any analytical result falls outside the agreed limits, we will replace the batch at no additional cost or issue a full refund.

Q6: How quickly can you provide a sample for evaluation?

A: A 100 mg “risk‑free” sample can be dispatched within 48 hours after receipt of a signed NDA.

Submit Your Inquiry Now

Act Now – Limited Stock & Exclusive Offer

Only 5 kg of our high‑purity Larazotide are reserved for new clients this quarter. Secure your allocation before the price adjustment on June 30, 2026.

  • Free 100 mg sample – no‑cost, no‑obligation
  • Money‑back guarantee if specifications are not met
  • Dedicated account manager for the entire procurement cycle
Reserve Your Stock Today

Contact us via WhatsApp +86 19943830844, email service@huanqiukeji9.com, or fill out the form on our Contact Page.

What Our Clients Say

Client: John Miller, Procurement Lead, BioPharma Solutions (USA)

“The 30‑day delivery exceeded our expectations. The CoA was crystal‑clear, and the batch performed flawlessly in our GLP studies.”

Client: Sofia Rossi, R&D Manager, MedTech Italia

“Customization was seamless. We received a tailored free‑base form within two weeks, cutting our formulation timeline by 20 %.”

Client: David Kim, Supply Chain Director, Genex Pharmaceuticals (Korea)

“Pricing was transparent, and the DDP shipping eliminated hidden fees. Our total landed cost dropped by 18 %.”

About the Author

Dr. Li Wei, Ph.D. – Senior API Development Director at Global Technology Co., Ltd, with over 15 years of experience in peptide synthesis, GMP compliance, and international regulatory affairs. Dr. Wei has authored 42 peer‑reviewed papers on peptide therapeutics and serves on the advisory board of the International Society for Peptide Research.

Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844

© 2026 Global Technology Co., Ltd. All rights reserved. Privacy Policy | Terms of Service

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.